SRS
Overview
SRS is a French private equity firm specializing in healthcare investments, providing long-term support for the national and international development of its portfolio companies. With over 40 years of experience in the healthcare and medical-social services sectors, SRS acts as a majority or significant minority shareholder in companies of all sizes, from innovative startups to international leaders. Its holdings span the entire care pathway for individuals made vulnerable by age, disability, or illness. SRS's investment strategy focuses on sectors such as housing, ecology, support, and care for people weakened by age or illness. The firm aims to build the future of modern Western societies, which are facing an aging population. Notable investments include DomusVi, Alma Viva, Sedna, and Emera, with a vision for the future represented by Apt Renaissance and Majycc. These companies are human-centered and supportive, bridging generations and promoting social consensus. They are growth-oriented and will face an exponential increase in demand over the next 15 years. The firm's values include expertise in managing healthcare facilities, a stable shareholder base since its creation, real international know-how, long-term support for its companies' growth, true expertise in new and digital technologies to build the health of tomorrow, and great flexibility in equity investments. SRS is present in many European countries, North America, and Latin America, and launched Majycc in 2018, a smart money investment vehicle specialized in e-health. The firm is committed to corporate social responsibility, supporting initiatives to improve and reduce the environmental impact of its activities, being a player in its subsidiaries' transformation in relation to social and societal issues, and implementing exemplary governance in line with its values. SRS's team has considerable experience in managing establishments, administrative and financial management, and real estate expertise. The firm's main objective is to invest in an entrepreneurial approach alongside a team with a project offering ambitious organic and/or external growth potential.
Investment Focus
- Entrepreneurial approach
- Ambitious growth potential
- Focus on healthcare sector
Portfolio Companies
Reach SRS directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about SRS
What sectors does SRS invest in?
SRS invests in Healthcare, Pharmaceuticals, Medical Devices, Biotechnology, Medical Research and Medical Equipment, and is based in Provence-Alpes-Côte D'azur, France. SRS is listed as a private equity in the ConnectSafely investor database.
What stage does SRS invest at?
SRS backs companies at Seed, Early Stage, Growth, Late Stage and Buyout, writing cheques of 1M - 50M.
Which regions does SRS invest in?
SRS invests across United States, Canada, Germany, Brazil, France and Spain.
What companies has SRS invested in?
SRS's portfolio includes Emera, DomusVi, Alma Viva, Sedna, Apt Renaissance and Majycc.
How do I contact SRS?
SRS's contact details — including phone — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database